» Articles » PMID: 33951649

The Association Between Adherence to the MIND Diet and Irritable Bowel Syndrome

Overview
Journal Dig Dis
Specialty Gastroenterology
Date 2021 May 5
PMID 33951649
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: No earlier study examined the association between adherence to the MIND (Mediterranean-DASH Diet Intervention for Neurodegenerative Delay) diet and odds of irritable bowel syndrome (IBS). This study was conducted to examine the relationship between adherence to the MIND diet and odds of IBS among Iranian adults.

Methods: In this cross-sectional study, dietary intakes of 3,362 adults were examined using a validated Dish-Based 106-item Semi-Quantitative Food Frequency Questionnaire (DS-FFQ). The MIND diet score was constructed based on participants' dietary intakes obtained from DS-FFQ. IBS was evaluated using a modified Persian version of the Rome III questionnaire.

Results: Overall, 22.2% of the study population were affected by IBS (n = 748). We observed no significant relationship between adherence to the MIND diet and odds of IBS in the whole population (OR: 0.97; 95% CI: 0.71-1.31). By gender and BMI status, no significant association between adherence to the MIND diet and odds of IBS was seen. Also, no significant association was found between adherence to the MIND diet and IBS subtypes.

Conclusion: No significant association was found between adherence to the MIND diet and odds of IBS. Further studies are needed to examine the association between dietary patterns and IBS.

Citing Articles

Evaluation of dietary quality in patients with functional gastrointestinal symptoms: a Norwegian single centre study.

Holm I, Lorentzen S, Carlsen M, Valeur J, Mellin-Olsen T, Dale H Food Nutr Res. 2025; 68.

PMID: 39781271 PMC: 11708516. DOI: 10.29219/fnr.v68.10692.


MIND Diet Adherence Might be Associated with a Reduced Odds of Multiple Sclerosis: Results from a Case-Control Study.

Noormohammadi M, Ghorbani Z, Naser Moghadasi A, Saeedirad Z, Shahemi S, Ghanaatgar M Neurol Ther. 2022; 11(1):397-412.

PMID: 35094301 PMC: 8857348. DOI: 10.1007/s40120-022-00325-z.